/arc-anglerfish-arc2-prod-infobae.s3.amazonaws.com/public/4QTEBSM3WZGK5O4WEXR2ENHCCE.jpg "The first kit to test for coronavirus at home goes on sale in the United States")
The United States Food and Drug Administration (FDA) authorized the first kit to perform a coronavirus test at home.
– –
The kit is produced by the company LabCorp, which announced that it will first make it available to health and medical emergency workers and will then go on sale to the public at a cost of $ 119.
– –
The kit actually It is not a complete self-test that gives a result, like others that are still in the testing phase. In this case, the box It includes a swab that people must enter their nose and obtain a fluid sample that they must then send to the laboratory for analysis and results.. Still, the possibility of obtaining the sample yourself avoids the need to go to a medical center to do so, thus reducing possible contact with symptomatic patients. In addition, it releases tests and equipment that medical personnel need.
– –
This swab will obtain the sample just entering it into the nostril and will be as accurate as those taken in laboratories with more invasive methods that reach the bottom of the nose, according to studies.
– –
The test prepared by LabCorp, which will be sold under the trademarkl “Pixel” It is the first to obtain authorization for a dozen submitted by various laboratories. It was approved under the emergency rules that apply during the pandemic, as it did not complete the normal approval process.
– –
In the United States, some 147,000 tests are carried out per day, a number that experts still consider low to monitor the advance of the pandemic in the country, which has already produced more than 40,000 deaths.
– –
CRISPR, the tool that cuts and edits DNA, with the consequent potential to cure a wide range of diseases, is the latest innovation in the search for a analysis to detect the coronavirus.
– –
The new generation of these tests could take advantage of the capabilities of CRISPR, according to a new study by the San Francisco School of Medicine, University of California (UCSF), and Mammoth Biosciences. Posted on April 16 in Nature Biotechnology, presented the hope of a quick and inexpensive examination, which is carried out on samples obtained with a simple swab of the nose or throat. The CRISPR-Cas12 system recognizes the genetic signatures of SARS-CoV-2 and cuts them to reveal a fluorescent molecule, which shows the presence of the virus.
– –
In the same way as the analyzes approved by the Center for Disease Control and Prevention (CDC) of the United States, the new method — whose job name is DETECTR– You can process multiple samples at once, with the advantage of providing results not in hours, like that of the CDC, but between 30 and 45 minutes.
– –
